Alan H. Mutnick

1.6k total citations
41 papers, 1.1k citations indexed

About

Alan H. Mutnick is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Geriatrics and Gerontology. According to data from OpenAlex, Alan H. Mutnick has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Pediatrics, Perinatology and Child Health and 8 papers in Geriatrics and Gerontology. Recurrent topics in Alan H. Mutnick's work include Pharmaceutical Practices and Patient Outcomes (8 papers), Pharmaceutical studies and practices (8 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Alan H. Mutnick is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (8 papers), Pharmaceutical studies and practices (8 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Alan H. Mutnick collaborates with scholars based in United States, Canada and Australia. Alan H. Mutnick's co-authors include Ronald N. Jones, Douglas J. Biedenbach, Robert Rennie, Virve I. Enne, Daryl J. Hoban, John Turnidge, Jeffrey T. Kirby, Paul R. Rhomberg, Kelley A. Gordon and Mondell L. Beach and has published in prestigious journals such as Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy and Clinical Microbiology and Infection.

In The Last Decade

Alan H. Mutnick

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alan H. Mutnick United States	17	385	286	270	253	212	41	1.1k
Elizabeth D. Hermsen United States	22	384 1.0×	291 1.0×	295 1.1×	208 0.8×	278 1.3×	45	1.2k
Christopher W. Crank United States	19	842 2.2×	481 1.7×	462 1.7×	190 0.8×	195 0.9×	25	1.4k
Léonardo Pagani Italy	23	401 1.0×	186 0.7×	474 1.8×	280 1.1×	362 1.7×	68	1.7k
Michael Postelnick United States	26	696 1.8×	498 1.7×	486 1.8×	406 1.6×	754 3.6×	88	2.3k
Paul M. Beringer United States	22	333 0.9×	129 0.5×	362 1.3×	286 1.1×	500 2.4×	64	1.4k
Lucas Schulz United States	20	367 1.0×	317 1.1×	314 1.2×	119 0.5×	294 1.4×	77	1.1k
Linda Dresser Canada	17	727 1.9×	143 0.5×	377 1.4×	166 0.7×	343 1.6×	37	1.6k
Elizabeth Scicluna Malta	14	267 0.7×	146 0.5×	346 1.3×	252 1.0×	159 0.8×	22	1.1k
William Farrer United States	6	226 0.6×	256 0.9×	256 0.9×	252 1.0×	179 0.8×	10	993
Carole Fry United Kingdom	11	477 1.2×	215 0.8×	284 1.1×	113 0.4×	63 0.3×	18	1.0k

Countries citing papers authored by Alan H. Mutnick

Since Specialization

Citations

This map shows the geographic impact of Alan H. Mutnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan H. Mutnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan H. Mutnick more than expected).

Fields of papers citing papers by Alan H. Mutnick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan H. Mutnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan H. Mutnick. The network helps show where Alan H. Mutnick may publish in the future.

Co-authorship network of co-authors of Alan H. Mutnick

This figure shows the co-authorship network connecting the top 25 collaborators of Alan H. Mutnick. A scholar is included among the top collaborators of Alan H. Mutnick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan H. Mutnick. Alan H. Mutnick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mutnick, Alan H.. (2004). Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001). Journal of Antimicrobial Chemotherapy. 53(2). 290–296. 88 indexed citations

Rennie, Robert, Ronald N. Jones, & Alan H. Mutnick. (2003). Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000). Diagnostic Microbiology and Infectious Disease. 45(4). 287–293. 137 indexed citations

Mutnick, Alan H., Douglas J. Biedenbach, & Ronald N. Jones. (2003). Geographic variations and trends in antimicrobial resistance among Enterococcus faecalis and Enterococcus faecium in the SENTRY Antimicrobial Surveillance Program (1997–2000). Diagnostic Microbiology and Infectious Disease. 46(1). 63–68. 51 indexed citations

Sader, Hélio S., Thomas R. Fritsche, Alan H. Mutnick, & Ronald N. Jones. (2003). Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory tract pathogens (2000-2002). Diagnostic Microbiology and Infectious Disease. 47(3). 515–525. 25 indexed citations

Hoban, Daryl J., Douglas J. Biedenbach, Alan H. Mutnick, & Ronald N. Jones. (2003). Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000). Diagnostic Microbiology and Infectious Disease. 45(4). 279–285. 110 indexed citations

Deshpande, Lalitagauri M., Mondell L. Beach, Alan H. Mutnick, & Ronald N. Jones. (2003). Antimicrobial activity of LB10827, a new orally administered cephalosporin, tested against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae. Clinical Microbiology and Infection. 9(8). 893–896. 1 indexed citations

Gordon, Kelley A., Mondell L. Beach, Douglas J. Biedenbach, et al.. (2002). Antimicrobial susceptibility patterns of β-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997–2000). Diagnostic Microbiology and Infectious Disease. 43(2). 157–162. 54 indexed citations

Mutnick, Alan H., Douglas J. Biedenbach, John Turnidge, & Ronald N. Jones. (2002). Spectrum and potency evaluation of a new oxazolidinone, linezolid: report from the SENTRY Antimicrobial Surveillance Program, 1998–2000. Diagnostic Microbiology and Infectious Disease. 43(1). 65–73. 61 indexed citations

Jones, Ronald N., et al.. (2002). Impact of Modified Nonmeningeal Streptococcus pneumoniae Interpretive Criteria (NCCLS M100-S12) on the Susceptibility Patterns of Five Parenteral Cephalosporins: Report from the SENTRY Antimicrobial Surveillance Program (1997 to 2001). Journal of Clinical Microbiology. 40(11). 4332–4333. 16 indexed citations

10.

Bell, Edward F., et al.. (2002). Authorsʼ Reply:. Annals of Pharmacotherapy. 36. 535–535. 1 indexed citations

11.

Bell, Edward F., et al.. (2001). A Cost-Benefit Analysis of RSV Prophylaxis in High-Risk Infants. Annals of Pharmacotherapy. 35(10). 1186–1193. 22 indexed citations

12.

Dreher, Melanie C., et al.. (1999). University of Iowa Hospital and Clinics: Outcomes Management. Nursing Administration Quarterly. 24(1). 31–65. 2 indexed citations

13.

Mutnick, Alan H., et al.. (1998). Using multiple pharmacoeconomic methods to conduct a cost-effectiveness analysis of histamine H2-receptor antagonists. American Journal of Health-System Pharmacy. 55(suppl_4). S8–S12. 4 indexed citations

14.

Mutnick, Alan H. & Joshua Muscat. (1997). Primary Brain Cancer in Adults and the Use of Common Household Appliances: A Case-Control Study. Reviews on Environmental Health. 12(1). 59–62. 2 indexed citations

15.

Fain, John N., Peter E. Hilsenrath, John A. Widness, R. G. Strauss, & Alan H. Mutnick. (1995). A cost analysis comparing erythropoietin and red cell transfusions in the treatment of anemia of prematurity. Transfusion. 35(11). 936–943. 22 indexed citations

16.

Mutnick, Alan H., et al.. (1994). Application of Decision Analysis in Antibiotic Formulary Choices. Journal of Pharmacy Technology. 10(1). 23–26. 2 indexed citations

17.

Drea, Edward J., et al.. (1990). Cimetidine-Associated Adverse Reaction. DICP. 24(6). 581–583. 2 indexed citations

18.

Mutnick, Alan H., et al.. (1990). Dopamine versus Dobutamine: Are All the Facts There?. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 10(3). 224–229. 3 indexed citations

19.

Fish, Susan S., et al.. (1989). Clinical Pharmacy Education in New England: A Report of the Whispering Pines Conference. DICP. 23(11). 912–919.

20.

Figge, Helen L., James Figge, Paul F. Souney, Alan H. Mutnick, & Frank M. Sacks. (1988). Nicotinic Acid: A Review of Its Clinical Use in the Treatment of Lipid Disorders. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 8(5). 287–294. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact